Research Strategy
Alessandra Gaeta is Director of Research for Joining Jack and Duchenne UK. She joined the team in July 2021 with nearly 20 years of Research & Development experience in academia, industry & the public sector, where she held scientific, managerial and leadership roles. Throughout her career, Alessandra has particularly focussed on translational research and the value on cross-sector collaboration.
In previous roles in government funded organisations, Alessandra led on the creation of high-profile, national R&D programmes to accelerate innovative treatments to the clinic. At the Medicines Discovery Catapult, she established a portfolio of patient focused medicines discovery programmes in areas of unmet medical need, in partnership with charities and industry. Prior to that, at the NIHR, she was instrumental in the creation of the Translational Research Collaboration pilot programme for early phase clinical research, which has since been implemented in eight therapeutic areas.
Read about research projects here: https://www.duchenneuk.org/our-research/
Projects:
- Solid GT
- The Newcastle Plan
- Lectureship to develop clinical trial agenda
- Reveragen
- Tamoxifen Trial
- Summit PLC
- University of Geneva Combination and Repurposing Study
- Soy Products
- Halo Therapeutics
- Alder Hey Heart Protection Study
- The Duchenne Forum
- Cannabidiol (CBD)
- A Combination Study
- DMD Programme Co-ordinator
- Elastase Inhibitors
- Understanding the causes of heart disease in DMD
- Evox Therapeutics
- Tamoxifen Open Label Extension Study
- Adult Neuromuscular Complex Care Centre
- Testosterone Extension Study
- Creating new muscle by using stem cells
- Vamorolone
- Edasalonexent
- Tamoxifen clinical trial is fully recruited
- Orthotics pilot study
- Overcoming immunity challenges in gene therapy
- DMD Care UK
- Arrhythmias Update – October 2020
- Vamorolone Clinical trial success 2021
- Hydrotherapy for boys and young men with Duchenne
- Clinical Trials Lectureship
- Gene Therapy
- Project Hercules